Detection of minority drug resistant mutations in Malawian HIV-1 subtype C-positive patients initiating and on first-line antiretroviral therapy

• Asıl Yazarlar: Zhiyong Zhou (Yazar), Kevin Tang (Yazar), Guoqing Zhang (Yazar), Nellie Wadonda-Kabondo (Yazar), Kundai Moyo (Yazar), Lori A. Rowe (Yazar), Joshua R. DeVos (Yazar), Nick Wagar (Yazar), Du-Ping Zheng (Yazar), Hongxiong Guo (Yazar), John Nkengasong (Yazar), Mike Frace (Yazar), Scott Sammons (Yazar), Chunfu Yang (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: AOSIS, 2018-05-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Minority drug resistance mutations (DRMs) that are often missed by Sanger sequencing are clinically significant, as they can cause virologic failure in individuals treated with antiretroviral therapy (ART) drugs. Objective: This study aimed to estimate the prevalence of minor DRMs among...